Advanced Medical Solutions Group (LON:AMS) Receives “Buy” Rating from Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of Advanced Medical Solutions Group (LON:AMS – Get Rating) in a research note published on Wednesday morning, Marketbeat.com reports. Berenberg Bank currently has a GBX 310 ($3.78) price objective on the stock.

Advanced Medical Solutions Group Price Performance

LON AMS opened at GBX 226 ($2.75) on Wednesday. Advanced Medical Solutions Group has a 12 month low of GBX 225.50 ($2.75) and a 12 month high of GBX 319.50 ($3.89). The company has a debt-to-equity ratio of 4.28, a current ratio of 5.65 and a quick ratio of 4.58. The firm has a market capitalization of £490.22 million, a PE ratio of 2,825.00, a P/E/G ratio of 2.77 and a beta of 0.60. The company’s 50 day simple moving average is GBX 257.38 and its 200 day simple moving average is GBX 261.74.

Advanced Medical Solutions Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, June 9th. Investors of record on Thursday, May 18th will be paid a dividend of GBX 1.51 ($0.02) per share. This represents a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, May 18th. This is a positive change from Advanced Medical Solutions Group’s previous dividend of $0.64. Advanced Medical Solutions Group’s dividend payout ratio (DPR) is currently 2,500.00%.

About Advanced Medical Solutions Group

(Get Rating)

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.